The ESMO Daily Reporter recently published a summary of the insightful discussions on AI in oncology, a field that is transforming rapidly. Our very own co-founder and CTO, Dr. Mattias Rantalainen, chaired and contributed to this important track.
“AI brings a great advantage, and it is indeed possible to build robust models on a mixture of data from different scanners and different labs,” said Dr. Rantalainen.
At Stratipath, we’re proud to be at the forefront, delivering fast, affordable, and clinically validated AI-based diagnostics. It’s about achieving better outcomes, reducing wait times, and expanding access to precision medicine.
